Mitogen	O
activation	O
of	O
human	B-cell_type
peripheral	I-cell_type
T	I-cell_type
lymphocytes	I-cell_type
induces	O
the	O
formation	O
of	O
new	O
cyclic	B-protein
AMP	I-protein
response	I-protein
element-binding	I-protein
protein	I-protein
nuclear	I-protein
complexes	I-protein
.	O

A	O
large	O
body	O
of	O
evidence	O
indicates	O
that	O
experimental	O
agents	O
which	O
raise	O
cellular	O
cAMP	O
levels	O
inhibit	O
T	O
cell	O
growth	O
and	O
division	O
.	O

By	O
contrast	O
,	O
many	O
studies	O
have	O
reported	O
that	O
mitogen	B-protein
activation	O
of	O
T	B-cell_type
cells	I-cell_type
increases	O
cAMP	O
levels	O
,	O
implying	O
a	O
positive	O
physiological	O
role	O
for	O
cAMP	O
in	O
the	O
activation	O
process	O
.	O

In	O
the	O
present	O
study	O
we	O
demonstrate	O
that	O
mitogen	B-protein
activation	O
of	O
human	B-cell_type
peripheral	I-cell_type
T	I-cell_type
lymphocytes	I-cell_type
induces	O
nuclear	O
factors	O
that	O
form	O
complexes	O
with	O
cyclic	B-protein
AMP	I-protein
response	I-protein
element-binding	I-protein
protein	I-protein
(	O
CREB	B-protein
)	O
.	O

Four	O
complexes	O
are	O
identified	O
by	O
the	O
electrophoretic	O
mobility	O
shift	O
assay	O
,	O
two	O
of	O
which	O
are	O
induced	O
by	O
mitogen	B-protein
activation	O
.	O

All	O
four	O
complexes	O
contain	O
CREB	B-protein
and	O
are	O
bound	O
to	O
the	O
cAMP	B-DNA
response	I-DNA
element	I-DNA
(	I-DNA
CRE	I-DNA
)	I-DNA
core	I-DNA
sequence	I-DNA
(	O
TGACGTCA	O
)	O
,	O
as	O
indicated	O
by	O
antibody	O
and	O
oligonucleotide	O
competition	O
experiments	O
.	O

Binding	O
of	O
the	O
four	O
complexes	O
to	O
CRE	B-DNA
is	O
prevented	O
by	O
dephosphorylation	O
of	O
nuclear	O
extracts	O
and	O
is	O
restored	O
by	O
rephosphorylation	O
with	O
cAMP-dependent	B-protein
protein	I-protein
kinase	I-protein
or	O
endogenous	B-protein
kinases	I-protein
.	O

Similar	O
complexes	O
are	O
detected	O
in	O
nuclear	O
extracts	O
of	O
Jurkat	B-cell_line
cells	I-cell_line
.	O

Mitogen	O
induction	O
of	O
the	O
electrophoretic	B-protein
mobility	I-protein
shift	I-protein
assay	I-protein
complexes	I-protein
is	O
not	O
accounted	O
for	O
by	O
protein	O
phosphorylation	O
or	O
by	O
induction	O
of	O
CREB	B-protein
.	O

Rather	O
,	O
the	O
data	O
indicate	O
that	O
mitogen	O
increases	O
the	O
levels	O
of	O
a	O
nuclear	O
factor	O
(	O
s	O
)	O
that	O
dimerizes	O
with	O
CREB	B-protein
.	O

Induction	O
of	O
new	O
CREB	B-protein
complexes	I-protein
implies	O
a	O
physiological	O
role	O
for	O
cAMP	O
in	O
mitogen	B-protein
activation	O
of	O
T	B-cell_type
lymphocytes	I-cell_type
.	O

THz	NULL
Journar	NULL
or	NULL
Broroctcat	NULL
Carmistay	NULL
©	NULL
1994	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

269	NULL
,	NULL
No	NULL
.	NULL

31	NULL
,	NULL
Issue	NULL
of	NULL
August	NULL
5	NULL
,	NULL
pp	NULL
.	NULL

19719-19724	NULL
,	NULL
1994	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Mitogen	NULL
Activation	NULL
of	NULL
Human	NULL
Peripheral	NULL
T	NULL
Lymphocytes	NULL
Induces	NULL
the	NULL
Formation	NULL
of	NULL
New	NULL
Cyclic	NULL
AMP	NULL
Response	NULL
Element-binding	NULL
Protein	NULL
Nuclear	NULL
Complexes*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
February	NULL
9	NULL
,	NULL
1994	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
May	NULL
9	NULL
,	NULL
1994	NULL
)	NULL
Patrik	NULL
Wollberg	NULL
,	NULL
Henrik	NULL
Soderqvist	NULL
,	NULL
and	NULL
B	NULL
.	NULL

Dean	NULL
Nelson	NULL
}	NULL
From	NULL
the	NULL
Department	NULL
of	NULL
Biochemistry	NULL
,	NULL
Arrhenius	NULL
Laboratories	NULL
,	NULL
Stockholm	NULL
University	NULL
,	NULL
8-106	NULL
91	NULL
Stockholm	NULL
,	NULL
Sweden	NULL
A	NULL
large	NULL
body	NULL
of	NULL
evidence	NULL
indicates	NULL
that	NULL
experimental	NULL
agents	NULL
which	NULL
raise	NULL
cellular	NULL
cAMP	NULL
levels	NULL
inhibit	NULL
T	NULL
cell	NULL
growth	NULL
and	NULL
division	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
many	NULL
studies	NULL
have	NULL
reported	NULL
that	NULL
mitogen	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
increases	NULL
cAMP	NULL
levels	NULL
,	NULL
implying	NULL
a	NULL
positive	NULL
physiological	NULL
role	NULL
for	NULL
cAMP	NULL
in	NULL
the	NULL
activation	NULL
process	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
we	NULL
demonstrate	NULL
that	NULL
mitogen	NULL
activation	NULL
of	NULL
human	NULL
peripheral	NULL
T	NULL
lymphocytes	NULL
induces	NULL
nuclear	NULL
factors	NULL
that	NULL
form	NULL
complexes	NULL
with	NULL
cyclic	NULL
AMP	NULL
response	NULL
element-binding	NULL
protein	NULL
(	NULL
CREB	NULL
)	NULL
.	NULL

Four	NULL
complexes	NULL
are	NULL
identified	NULL
by	NULL
the	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
,	NULL
two	NULL
of	NULL
which	NULL
are	NULL
induced	NULL
by	NULL
mitogen	NULL
activation	NULL
.	NULL

All	NULL
four	NULL
complexes	NULL
contain	NULL
CREB	NULL
and	NULL
are	NULL
bound	NULL
to	NULL
the	NULL
cAMP	NULL
response	NULL
element	NULL
(	NULL
CRE	NULL
)	NULL
core	NULL
sequence	NULL
(	NULL
TGACGTCA	NULL
)	NULL
,	NULL
as	NULL
indicated	NULL
by	NULL
antibody	NULL
and	NULL
oligonucleotide	NULL
competition	NULL
experiments	NULL
.	NULL

Binding	NULL
of	NULL
the	NULL
four	NULL
complexes	NULL
to	NULL
CRE	NULL
is	NULL
prevented	NULL
by	NULL
dephosphorylation	NULL
of	NULL
nuclear	NULL
extracts	NULL
and	NULL
is	NULL
restored	NULL
by	NULL
rephosphorylation	NULL
with	NULL
cAMP-dependent	NULL
protein	NULL
kinase	NULL
or	NULL
endogenous	NULL
kinases	NULL
.	NULL

Similar	NULL
complexes	NULL
are	NULL
detected	NULL
in	NULL
nuclear	NULL
extracts	NULL
of	NULL
Jurkat	NULL
cells	NULL
.	NULL

Mitogen	NULL
induction	NULL
of	NULL
the	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
complexes	NULL
is	NULL
not	NULL
accounted	NULL
for	NULL
by	NULL
protein	NULL
phosphorylation	NULL
or	NULL
by	NULL
induction	NULL
of	NULL
CREB	NULL
.	NULL

Rather	NULL
,	NULL
the	NULL
data	NULL
indicate	NULL
that	NULL
mitogen	NULL
increases	NULL
the	NULL
levels	NULL
of	NULL
a	NULL
nuclear	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
that	NULL
dimerizes	NULL
with	NULL
CREB	NULL
.	NULL

Induction	NULL
of	NULL
new	NULL
CREB	NULL
complexes	NULL
implies	NULL
a	NULL
physiological	NULL
role	NULL
for	NULL
cAMP	NULL
in	NULL
mitogen	NULL
activation	NULL
of	NULL
T	NULL
lymphocytes	NULL
.	NULL

The	NULL
role	NULL
played	NULL
by	NULL
cAMP	NULL
in	NULL
the	NULL
growth	NULL
and	NULL
division	NULL
of	NULL
T	NULL
lymphocytes	NULL
is	NULL
complex	NULL
and	NULL
poorly	NULL
understood	NULL
.	NULL

A	NULL
large	NULL
number	NULL
of	NULL
investigations	NULL
have	NULL
shown	NULL
that	NULL
cyclic	NULL
AMP	NULL
analogues	NULL
,	NULL
or	NULL
other	NULL
experimental	NULL
agents	NULL
that	NULL
elevate	NULL
intracellular	NULL
levels	NULL
of	NULL
cAMP	NULL
,	NULL
inhibit	NULL
T	NULL
cell	NULL
growth	NULL
and	NULL
DNA	NULL
synthesis	NULL
(	NULL
1-6	NULL
)	NULL
.	NULL

The	NULL
step	NULL
in	NULL
the	NULL
signal	NULL
cascade	NULL
inhibited	NULL
by	NULL
cAMP	NULL
is	NULL
still	NULL
disputed	NULL
.	NULL

However	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
multiple	NULL
sites	NULL
are	NULL
most	NULL
likely	NULL
involved	NULL
.	NULL

Inhibition	NULL
of	NULL
early	NULL
initiation	NULL
events	NULL
leading	NULL
to	NULL
interleukin-2	NULL
production	NULL
(	NULL
2	NULL
,	NULL
3	NULL
,	NULL
8-13	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
late	NULL
interleukin-2-dependent	NULL
events	NULL
(	NULL
8	NULL
,	NULL
6	NULL
,	NULL
7	NULL
)	NULL
,	NULL
have	NULL
been	NULL
reported	NULL
.	NULL

Recent	NULL
studies	NULL
(	NULL
14	NULL
,	NULL
15	NULL
)	NULL
implicate	NULL
cAMP	NULL
as	NULL
an	NULL
inhibitor	NULL
of	NULL
the	NULL
Ras/Rafl	NULL
growth-activat-ing	NULL
pathway	NULL
.	NULL

In	NULL
spite	NULL
of	NULL
these	NULL
many	NULL
studies	NULL
demonstrating	NULL
an	NULL
inhibitory	NULL
role	NULL
of	NULL
cAMP	NULL
in	NULL
T	NULL
cell	NULL
growth	NULL
and	NULL
division	NULL
,	NULL
there	NULL
is	NULL
a	NULL
large	NULL
body	NULL
of	NULL
experimental	NULL
evidence	NULL
which	NULL
shows	NULL
that	NULL
mitogen	NULL
activation	NULL
induces	NULL
cellular	NULL
cAMP	NULL
levels	NULL
(	NULL
16-21	NULL
)	NULL
.	NULL

Most	NULL
of	NULL
these	NULL
studies	NULL
report	NULL
rapid	NULL
transitory	NULL
increases	NULL
in	NULL
cAMP	NULL
upon	NULL
mitogen	NULL
stimu-lation	NULL
,	NULL
but	NULL
others	NULL
report	NULL
late	NULL
(	NULL
21	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
sustained	NULL
(	NULL
19	NULL
)	NULL
,	NULL
increases	NULL
.	NULL

Such	NULL
findings	NULL
imply	NULL
a	NULL
positive	NULL
,	NULL
rather	NULL
than	NULL
negative	NULL
,	NULL
physiological	NULL
role	NULL
for	NULL
cAMP	NULL
in	NULL
cell	NULL
activation	NULL
.	NULL

They	NULL
also	NULL
focus	NULL
upon	NULL
the	NULL
need	NULL
to	NULL
differentiate	NULL
between	NULL
the	NULL
potential	NULL
pharma-cological	NULL
effects	NULL
of	NULL
cAMP	NULL
and	NULL
its	NULL
possible	NULL
physiological	NULL
functions	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
we	NULL
demonstrate	NULL
that	NULL
mitogen	NULL
stimulation	NULL
of	NULL
peripheral	NULL
T	NULL
lymphocytes	NULL
induces	NULL
CRE'-binding	NULL
complexes	NULL
not	NULL
present	NULL
in	NULL
non-activated	NULL
cells	NULL
.	NULL

These	NULL
complexes	NULL
all	NULL
contain	NULL
CREB	NULL
but	NULL
are	NULL
formed	NULL
by	NULL
induction	NULL
of	NULL
factors	NULL
that	NULL
bind	NULL
CREB	NULL
.	NULL

Induction	NULL
of	NULL
new	NULL
CREB	NULL
complexes	NULL
implies	NULL
a	NULL
role	NULL
for	NULL
cAMP	NULL
in	NULL
the	NULL
normal	NULL
physiological	NULL
regulation	NULL
of	NULL
T-lymphocyte	NULL
activation	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
Culture-Human	NULL
peripheral	NULL
T-lymphocytes	NULL
were	NULL
extracted	NULL
from	NULL
the	NULL
buffy	NULL
coats	NULL
of	NULL
healthy	NULL
blood	NULL
donors	NULL
and	NULL
purified	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Cells	NULL
(	NULL
2-5	NULL
x	NULL
10°	NULL
cells/ml	NULL
!	NULL
)	NULL

were	NULL
grown	NULL
overnight	NULL
in	NULL
RPMI	NULL
1640	NULL
media	NULL
containing	NULL
15	NULL
%	NULL
fetal	NULL
calf	NULL
sera	NULL
,	NULL
60	NULL
ug/ml	NULL
penicillin	NULL
,	NULL
160	NULL
ug/ml	NULL
streptomycin	NULL
,	NULL
and	NULL
0.3	NULL
mg/ml	NULL
1-glutamine	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
cultured	NULL
an	NULL
additional	NULL
48	NULL
h	NULL
in	NULL
either	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
concanava-lin	NULL
A	NULL
(	NULL
6	NULL
ug/ml	NULL
)	NULL
and	NULL
the	NULL
phorbol	NULL
ester	NULL
TPA	NULL
(	NULL
25	NULL
ng/ml	NULL
)	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
media	NULL
as	NULL
above	NULL
.	NULL

HepG2	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
media	NULL
containing	NULL
antibiotics	NULL
and	NULL
fetal	NULL
calf	NULL
sera	NULL
as	NULL
above	NULL
.	NULL

Nuclear	NULL
Extracts-Nuclear	NULL
extracts	NULL
from	NULL
mitogen-stimulated	NULL
and	NULL
non-stimulated	NULL
peripheral	NULL
T-lymphocytes	NULL
were	NULL
prepared	NULL
according	NULL
to	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

(	NULL
23	NULL
)	NULL
.	NULL

Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assay	NULL
(	NULL
EMSA	NULL
)	NULL
-Nuclear	NULL
extracts	NULL
were	NULL
preincubated	NULL
on	NULL
ice	NULL
for	NULL
15	NULL
min	NULL
in	NULL
15	NULL
mm	NULL
HEPES	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
3	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
4	NULL
mm	NULL
spermidine	NULL
,	NULL
5	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
glycerol	NULL
,	NULL
0.15	NULL
mm	NULL
EDTA	NULL
,	NULL
0.5	NULL
ug/ul	NULL
sheared	NULL
salmon	NULL
sperm	NULL
DNA	NULL
,	NULL
0.1	NULL
ug/ul	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
0.1	NULL
ug/ul	NULL
tRNA	NULL
,	NULL
1	NULL
mm	NULL
dithio-threitol	NULL
,	NULL
and	NULL
1	NULL
mm	NULL
phenylmethylsulfony	NULL
]	NULL
fluoride	NULL
.	NULL

Double-stranded	NULL
P-labeled	NULL
DNA	NULL
probe	NULL
(	NULL
30,000-60,000	NULL
cpm	NULL
)	NULL
was	NULL
added	NULL
alone	NULL
or	NULL
together	NULL
with	NULL
unlabeled	NULL
competing	NULL
oligonucleotides	NULL
as	NULL
indicated	NULL
in	NULL
the	NULL
individual	NULL
figure	NULL
legends	NULL
,	NULL
and	NULL
the	NULL
mixture	NULL
was	NULL
incubated	NULL
for	NULL
20	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

When	NULL
the	NULL
experiment	NULL
included	NULL
antibody	NULL
,	NULL
the	NULL
antibodies	NULL
and	NULL
nuclear	NULL
extract	NULL
were	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
30	NULL
min	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
olgionucleotide	NULL
mobility	NULL
shift	NULL
probe	NULL
,	NULL
DNA	NULL
binding	NULL
activity	NULL
was	NULL
monitored	NULL
by	NULL
the	NULL
EMSA	NULL
using	NULL
5	NULL
%	NULL
native	NULL
polyacrylamide	NULL
gels	NULL
in	NULL
180	NULL
mx	NULL
Tris	NULL
,	NULL
pH	NULL
8	NULL
,	NULL
180	NULL
my	NULL
borie	NULL
acid	NULL
,	NULL
4	NULL
mm	NULL
EDTA	NULL
,	NULL
5	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
glycerol	NULL
.	NULL

Antibodies	NULL
and	NULL
Recombinant	NULL
CREB-Anti-human	NULL
CREB-1	NULL
(	NULL
X-12	NULL
)	NULL
monoclonal	NULL
antibody	NULL
(	NULL
mouse	NULL
IgG1	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
.	NULL

This	NULL
antibody	NULL
was	NULL
raised	NULL
against	NULL
a	NULL
polypeptide	NULL
encompassing	NULL
the	NULL
basic	NULL
DNA	NULL
binding	NULL
domain	NULL
and	NULL
part	NULL
of	NULL
the	NULL
dimerization	NULL
domain	NULL
(	NULL
residues	NULL
254-327	NULL
)	NULL
of	NULL
the	NULL
human	NULL
43-kDa	NULL
CREB-1	NULL
protein	NULL
(	NULL
24	NULL
)	NULL
.	NULL

According	NULL
to	NULL
the	NULL
manufacturers	NULL
,	NULL
the	NULL
antibody	NULL
does	NULL
not	NULL
recognize	NULL
human	NULL
CREB-2	NULL
,	NULL
ATF1	NULL
,	NULL
ATF2	NULL
,	NULL
ATF3	NULL
,	NULL
or	NULL
ATFA4	NULL
.	NULL

Bacterially	NULL
expressed	NULL
recombinant	NULL
rat	NULL
CREBa	NULL
(	NULL
25	NULL
)	NULL
and	NULL
polyclonal	NULL
rabbit	NULL
Ig	NULL
antibodies	NULL
against	NULL
the	NULL
rat	NULL
CREBa	NULL
protein	NULL
(	NULL
25	NULL
)	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
J.	NULL
Lund	NULL
,	NULL
Novum	NULL
,	NULL
Huddinge	NULL
,	NULL
Sweden	NULL
.	NULL

*	NULL
This	NULL
study	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
Swedish	NULL
Cancer	NULL
Fund	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

{	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
46-8-162488	NULL
;	NULL
Fax	NULL
:	NULL
46-8-153679	NULL
.	NULL

'The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
CRE	NULL
,	NULL
cyclic	NULL
AMP	NULL
response	NULL
element	NULL
;	NULL
CREB	NULL
,	NULL
cyclic	NULL
AMP	NULL
response	NULL
element-binding	NULL
protein	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
LDH	NULL
,	NULL
lactate	NULL
dehydrogenase	NULL
;	NULL
LDHA	NULL
,	NULL
lactate	NULL
dehydrogenase	NULL
A	NULL
subunit	NULL
;	NULL
PKA	NULL
,	NULL
cyclic	NULL
AMP-dependent	NULL
protein	NULL
ki-nase	NULL
;	NULL
TPA	NULL
,	NULL
12-O-tetradecanoylphorbol-13-acetate	NULL
;	NULL
AP1	NULL
,	NULL
transcription	NULL
factor	NULL
APL	NULL
.	NULL

19719	NULL
19720	NULL
Phosphorylation	NULL
and	NULL
Dephosphorylation	NULL
of	NULL
Nuclear	NULL
Extracts-Nuclear	NULL
extracts	NULL
were	NULL
dephosphorylated	NULL
with	NULL
potato	NULL
acid	NULL
phosphatase	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
linked	NULL
to	NULL
CNBr-activated	NULL
Sepharose	NULL
CL-4B	NULL
(	NULL
Pharmacia	NULL
Biotech	NULL
Inc.	NULL
)	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Equal	NULL
volumes	NULL
of	NULL
sample	NULL
and	NULL
gel	NULL
were	NULL
incubated	NULL
in	NULL
a	NULL
batch	NULL
procedure	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
20	NULL
mm	NULL
Tris	NULL
,	NULL
pH	NULL
7.2	NULL
,	NULL
1	NULL
mm	NULL
EDTA	NULL
,	NULL
5	NULL
%	NULL
glycerol	NULL
,	NULL
and	NULL
2	NULL
mm	NULL
2-mercaptoethanol	NULL
.	NULL

Aliquots	NULL
of	NULL
the	NULL
supernatants	NULL
were	NULL
rephosphorylated	NULL
upon	NULL
incubation	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
6	NULL
units	NULL
of	NULL
the	NULL
catalytic	NULL
subunit	NULL
of	NULL
porcine	NULL
cAMP-dependent	NULL
protein	NULL
kinase	NULL
(	NULL
PKA	NULL
)	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
10	NULL
my	NULL
Tris	NULL
,	NULL
pH	NULL
7.5	NULL
,	NULL
10	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
1	NULL
mm	NULL
ATP	NULL
,	NULL
1	NULL
mu	NULL
sodium	NULL
vanadate	NULL
,	NULL
50	NULL
mm	NULL
NaF	NULL
,	NULL
and	NULL
1	NULL
mm	NULL
dithiothreitol	NULL
for	NULL
1	NULL
h	NULL
at	NULL
30	NULL
°C	NULL
.	NULL

Western	NULL
Blot	NULL
Analysis	NULL
of	NULL
the	NULL
CREB-1	NULL
Protein-10	NULL
ug	NULL
of	NULL
nuclear	NULL
extract	NULL
was	NULL
separated	NULL
on	NULL
10	NULL
%	NULL
acrylamide	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Laemmli	NULL
(	NULL
27	NULL
)	NULL
using	NULL
midget	NULL
gels	NULL
.	NULL

Blotting	NULL
was	NULL
performed	NULL
using	NULL
an	NULL
LKB	NULL
model	NULL
0251	NULL
transfer	NULL
unit	NULL
.	NULL

After	NULL
blotting	NULL
,	NULL
the	NULL
nitrocellulose	NULL
filter	NULL
was	NULL
stained	NULL
with	NULL
Ponceau	NULL
Red	NULL
to	NULL
localize	NULL
the	NULL
molecular	NULL
weight	NULL
markers	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
blocked	NULL
overnight	NULL
with	NULL
0.2	NULL
%	NULL
Tween	NULL
,	NULL
5	NULL
%	NULL
fat-free	NULL
milk	NULL
powder	NULL
,	NULL
50	NULL
ma	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
and	NULL
0.01	NULL
%	NULL
NaN	NULL
,	NULL
in	NULL
PBS	NULL
.	NULL

They	NULL
were	NULL
then	NULL
incubated	NULL
with	NULL
monoclonal	NULL
mouse	NULL
IgG1	NULL
anti	NULL
human	NULL
CREB-1	NULL
antibodies	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
washed	NULL
four	NULL
times	NULL
for	NULL
15	NULL
min	NULL
in	NULL
blocking	NULL
solution	NULL
,	NULL
and	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
alkaline	NULL
phosphatase-conjugated	NULL
goat	NULL
anti-mouse	NULL
antibody	NULL
(	NULL
Dako	NULL
,	NULL
Denmark	NULL
)	NULL
.	NULL

The	NULL
bands	NULL
were	NULL
visualized	NULL
using	NULL
an	NULL
alkaline	NULL
phosphatase	NULL
conjugate	NULL
substrate	NULL
kit	NULL
(	NULL
Bio-Rad	NULL
)	NULL
and	NULL
quantified	NULL
using	NULL
a	NULL
laser	NULL
densitometer	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
)	NULL
.	NULL

Synthetic	NULL
Oligonucleotide	NULL
Probes-The	NULL
LDHA-CRE	NULL
oligonucleotide	NULL
(	NULL
5'-GCTCCCACTCTGACGTCAGCGCGGAGCTT-3	NULL
'	NULL
)	NULL
is	NULL
from	NULL
the	NULL
5	NULL
regulatory	NULL
region	NULL
(	NULL
nucleotides	NULL
-59	NULL
to	NULL
-30	NULL
)	NULL
of	NULL
the	NULL
mouse	NULL
LDHA	NULL
gene	NULL
(	NULL
28	NULL
)	NULL
,	NULL
and	NULL
the	NULL
LDHA	NULL
control	NULL
oligonucleotide	NULL
(	NULL
5'-CCATTTAAGGCCCCGC-CGCGTGCTGCTCT-3	NULL
'	NULL
)	NULL
corresponds	NULL
to	NULL
nucleotides	NULL
-29	NULL
to	NULL
-1	NULL
of	NULL
the	NULL
mouse	NULL
LDHA	NULL
regulatory	NULL
region	NULL
.	NULL

Other	NULL
synthetic	NULL
oligonucleotides	NULL
contained	NULL
the	NULL
AP1	NULL
consensus	NULL
motif	NULL
(	NULL
5'-CCACTCTGAGTCAGCGCGGAG-3	NULL
'	NULL
)	NULL
,	NULL
the	NULL
SP1	NULL
consensus	NULL
motif	NULL
(	NULL
5'-GCCCGGCCCCGCCCcCcaGcaéGcTCceccC-3	NULL
'	NULL
)	NULL
,	NULL
the	NULL
glucocorticoid	NULL
response	NULL
element	NULL
(	NULL
29	NULL
)	NULL
,	NULL
the	NULL
estrogen	NULL
response	NULL
element	NULL
(	NULL
30	NULL
)	NULL
,	NULL
or	NULL
the	NULL
xenobiotic	NULL
response	NULL
element	NULL
(	NULL
30	NULL
)	NULL
.	NULL

All	NULL
probes	NULL
were	NULL
double-stranded	NULL
and	NULL
5'-end-labeled	NULL
with	NULL
[	NULL
*PJATP	NULL
using	NULL
polynucleotide	NULL
kinase	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
.	NULL

RESULTS	NULL
Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
peripheral	NULL
T	NULL
lymphocytes	NULL
incubated	NULL
for	NULL
48	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
mitogen	NULL
(	NULL
concanavalin	NULL
A	NULL
and	NULL
TPA	NULL
)	NULL
.	NULL

The	NULL
extracts	NULL
were	NULL
analyzed	NULL
for	NULL
CRE-binding	NULL
proteins	NULL
by	NULL
EMSA	NULL
using	NULL
an	NULL
oligonucleotide	NULL
probe	NULL
(	NULL
LDHA-CRE	NULL
)	NULL
from	NULL
the	NULL
5	NULL
'	NULL
regulatory	NULL
region	NULL
of	NULL
the	NULL
mouse	NULL
LDHA	NULL
gene	NULL
(	NULL
28	NULL
)	NULL
.	NULL

LDHA-CRE	NULL
contains	NULL
a	NULL
perfect	NULL
,	NULL
palindromic	NULL
CRE	NULL
sequence	NULL
(	NULL
5-TGACGTCA-3	NULL
'	NULL
)	NULL
,	NULL
which	NULL
functions	NULL
within	NULL
the	NULL
context	NULL
of	NULL
the	NULL
LDHA	NULL
gene	NULL
as	NULL
a	NULL
cAMP	NULL
response	NULL
element	NULL
(	NULL
31	NULL
,	NULL
32	NULL
)	NULL
.	NULL

Two	NULL
broad	NULL
bands	NULL
are	NULL
formed	NULL
with	NULL
LDHA-CRE	NULL
upon	NULL
incubation	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
activated	NULL
T	NULL
lymphocytes	NULL
:	NULL
a	NULL
low	NULL
mobility	NULL
A	NULL
band	NULL
and	NULL
a	NULL
higher	NULL
mobility	NULL
B	NULL
band	NULL
.	NULL

Both	NULL
the	NULL
A	NULL
and	NULL
B	NULL
bands	NULL
are	NULL
composed	NULL
of	NULL
two	NULL
separate	NULL
complexes	NULL
(	NULL
complexes	NULL
Al	NULL
and	NULL
A2	NULL
and	NULL
complexes	NULL
B1	NULL
and	NULL
B2	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
which	NULL
are	NULL
not	NULL
always	NULL
clearly	NULL
resolved	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Mitogen	NULL
activation	NULL
induces	NULL
complexes	NULL
A1	NULL
and	NULL
A2	NULL
formation	NULL
.	NULL

A	NULL
weak	NULL
A2	NULL
complex	NULL
is	NULL
occasionally	NULL
observed	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
non-stimulated	NULL
T	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
the	NULL
A1	NULL
complex	NULL
is	NULL
only	NULL
detected	NULL
with	NULL
nuclear	NULL
lysates	NULL
from	NULL
mitogen-activated	NULL
cells	NULL
.	NULL

To	NULL
demonstrate	NULL
that	NULL
CREB	NULL
(	NULL
see	NULL
Refs	NULL
.	NULL

33	NULL
and	NULL
34	NULL
for	NULL
review	NULL
)	NULL
binds	NULL
to	NULL
LDHA-CRE	NULL
,	NULL
a	NULL
series	NULL
of	NULL
oligonucleotide	NULL
competition	NULL
experiments	NULL
were	NULL
conducted	NULL
.	NULL

The	NULL
experiment	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
shows	NULL
that	NULL
the	NULL
LDHA-CRE	NULL
oligonucleotide	NULL
competes	NULL
more	NULL
efficiently	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
than	NULL
the	NULL
AP1	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
labeled	NULL
LDHA-CRE	NULL
probe	NULL
.	NULL

The	NULL
binding	NULL
elements	NULL
in	NULL
API	NULL
(	NULL
TGAGTCA	NULL
)	NULL
and	NULL
LDHA-CRE	NULL
(	NULL
TGACGTCA	NULL
)	NULL
differ	NULL
by	NULL
a	NULL
single	NULL
nucleotide	NULL
,	NULL
providing	NULL
strong	NULL
evidence	NULL
that	NULL
CREB	NULL
or	NULL
a	NULL
CREB-related	NULL
protein	NULL
binds	NULL
LDHA-CRE	NULL
.	NULL

The	NULL
results	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
also	NULL
indicate	NULL
that	NULL
all	NULL
four	NULL
complexes	NULL
contain	NULL
a	NULL
core	NULL
CREB	NULL
or	NULL
CREB-related	NULL
protein	NULL
bound	NULL
at	NULL
the	NULL
CRE	NULL
site	NULL
.	NULL

However	NULL
,	NULL
more	NULL
competitor	NULL
LDHA-CRE	NULL
is	NULL
required	NULL
to	NULL
inhibit	NULL
A1	NULL
and	NULL
A2	NULL
formation	NULL
than	NULL
to	NULL
inhibit	NULL
B1	NULL
and	NULL
B2	NULL
formation	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

This	NULL
data	NULL
indicates	NULL
either	NULL
that	NULL
A1	NULL
and	NULL
A2	NULL
are	NULL
present	NULL
in	NULL
nuclear	NULL
extracts	NULL
of	NULL
activated	NULL
cells	NULL
in	NULL
higher	NULL
amounts	NULL
than	NULL
the	NULL
B	NULL
complexes	NULL
or	NULL
that	NULL
the	NULL
B	NULL
complexes	NULL
have	NULL
a	NULL
higher	NULL
affinity	NULL
for	NULL
LDHA-CRE	NULL
.	NULL

Induction	NULL
of	NULL
CREB	NULL
Complexes	NULL
in	NULL
T	NULL
Lymphocytes	NULL
Mitogen	NULL
-	NULL
+	NULL
A1	NULL
,	NULL
A2	NULL
B1	NULL
-	NULL
f	NULL
*	NULL
B2	NULL
-	NULL
¢	NULL
FREE	NULL
PROBE	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

Mitogen	NULL
activation	NULL
of	NULL
peripheral	NULL
T	NULL
lymphocytes	NULL
induces	NULL
additional	NULL
nuclear	NULL
CRE	NULL
binding	NULL
activity	NULL
.	NULL

Peripheral	NULL
human	NULL
T	NULL
lymphocytes	NULL
were	NULL
incubated	NULL
48	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
of	NULL
mitogen	NULL
(	NULL
concanavalin	NULL
A	NULL
and	NULL
TPA	NULL
)	NULL
.	NULL

Nuclear	NULL
lysates	NULL
were	NULL
tested	NULL
for	NULL
CRE	NULL
binding	NULL
activity	NULL
by	NULL
EMSA	NULL
.	NULL

A	NULL
synthetic	NULL
double-stranded	NULL
oligonucleotide	NULL
from	NULL
the	NULL
mouse	NULL
gene	NULL
LDHA-CRE	NULL
containing	NULL
a	NULL
functional	NULL
cyclie	NULL
AMP	NULL
response	NULL
element	NULL
(	NULL
TGACGTCA	NULL
)	NULL
was	NULL
used	NULL
as	NULL
the	NULL
probe	NULL
.	NULL

Four	NULL
complexes	NULL
,	NULL
designated	NULL
A1	NULL
,	NULL
A2	NULL
,	NULL
B1	NULL
,	NULL
and	NULL
B2	NULL
,	NULL
were	NULL
formed	NULL
in	NULL
mitogen-treated	NULL
cells	NULL
.	NULL

Only	NULL
complexes	NULL
B1	NULL
and	NULL
B2	NULL
were	NULL
present	NULL
in	NULL
the	NULL
nuclear	NULL
extract	NULL
from	NULL
non-stimulated	NULL
cells	NULL
.	NULL

Gel	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

40	NULL
ug	NULL
of	NULL
protein	NULL
was	NULL
loaded	NULL
in	NULL
each	NULL
well	NULL
.	NULL

To	NULL
further	NULL
establish	NULL
the	NULL
CRE	NULL
specificity	NULL
of	NULL
the	NULL
DNA-binding	NULL
protein	NULL
,	NULL
the	NULL
converse	NULL
EMSA	NULL
competition	NULL
experiments	NULL
were	NULL
con-ducted	NULL
,	NULL
i.e	NULL
.	NULL

the	NULL
AP1	NULL
oligonucleotide	NULL
was	NULL
used	NULL
as	NULL
the	NULL
probe	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
non-activated	NULL
T-lymphocytes	NULL
formed	NULL
a	NULL
weak	NULL
A2	NULL
complex	NULL
with	NULL
the	NULL
AP1	NULL
oligonucleotide	NULL
,	NULL
whereas	NULL
stronger	NULL
A1	NULL
and	NULL
A2	NULL
complexes	NULL
were	NULL
formed	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
mitogen-activated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
C	NULL
and	NULL
D	NULL
)	NULL
.	NULL

However	NULL
,	NULL
all	NULL
complexes	NULL
were	NULL
competed	NULL
more	NULL
efficiently	NULL
by	NULL
LDHA-CRE	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
than	NULL
by	NULL
the	NULL
AP1	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

2D	NULL
)	NULL
.	NULL

B1	NULL
and	NULL
B2	NULL
complexes	NULL
were	NULL
not	NULL
detected	NULL
with	NULL
the	NULL
AP1	NULL
oligonucleotide	NULL
as	NULL
probe	NULL
.	NULL

These	NULL
experiments	NULL
support	NULL
the	NULL
conclusion	NULL
that	NULL
a	NULL
CREB-related	NULL
factor	NULL
participates	NULL
in	NULL
formation	NULL
of	NULL
all	NULL
four	NULL
complexes	NULL
.	NULL

They	NULL
also	NULL
confirm	NULL
published	NULL
studies	NULL
indicating	NULL
that	NULL
CREB	NULL
can	NULL
form	NULL
weak	NULL
complexes	NULL
with	NULL
the	NULL
AP1	NULL
element	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Competition	NULL
experiments	NULL
were	NULL
also	NULL
carried	NULL
out	NULL
using	NULL
competitor	NULL
oligonucleotides	NULL
bearing	NULL
the	NULL
glucocorticosteroid	NULL
response	NULL
element	NULL
(	NULL
29	NULL
)	NULL
,	NULL
the	NULL
xenobiotic	NULL
response	NULL
element	NULL
(	NULL
30	NULL
)	NULL
,	NULL
estrogen	NULL
receptor	NULL
element	NULL
(	NULL
30	NULL
)	NULL
,	NULL
a	NULL
single	NULL
Sp1	NULL
site	NULL
(	NULL
CCGCCC	NULL
)	NULL
,	NULL
or	NULL
a	NULL
control	NULL
sequence	NULL
immediately	NULL
3	NULL
'	NULL
of	NULL
the	NULL
LDHA-CRE	NULL
region	NULL
in	NULL
the	NULL
LDH-A	NULL
gene	NULL
(	NULL
28	NULL
)	NULL
.	NULL

None	NULL
of	NULL
these	NULL
oligonuceotides	NULL
competed	NULL
with	NULL
LDHA-CRE	NULL
,	NULL
even	NULL
at	NULL
high	NULL
molar	NULL
excess	NULL
ratios	NULL
(	NULL
500-fold	NULL
,	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
above	NULL
oligonucleotides	NULL
were	NULL
also	NULL
used	NULL
as	NULL
EMSA	NULL
probes	NULL
,	NULL
and	NULL
although	NULL
complexes	NULL
were	NULL
formed	NULL
with	NULL
T	NULL
lymphocyte	NULL
nuclear	NULL
extracts	NULL
,	NULL
none	NULL
were	NULL
competed	NULL
out	NULL
by	NULL
unlabeled	NULL
LDHA-CRE	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
the	NULL
A	NULL
and	NULL
B	NULL
complexes	NULL
contained	NULL
CREB	NULL
,	NULL
we	NULL
used	NULL
a	NULL
monoclonal	NULL
antibody	NULL
specific	NULL
for	NULL
the	NULL
human	NULL
43-kDa	NULL
CREB-1	NULL
protein	NULL
that	NULL
was	NULL
directed	NULL
against	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
(	NULL
residues	NULL
254-327	NULL
)	NULL
.	NULL

Fig	NULL
.	NULL

3	NULL
shows	NULL
a	NULL
titration	NULL
of	NULL
lymphocyte	NULL
nuclear	NULL
extracts	NULL
with	NULL
antibody	NULL
.	NULL

The	NULL
monoclonal	NULL
antibody	NULL
abolished	NULL
complex	NULL
formation	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
both	NULL
non-stimulated	NULL
and	NULL
mitogen-stimulated	NULL
cells	NULL
.	NULL

The	NULL
same	NULL
result	NULL
was	NULL
obtained	NULL
with	NULL
polyclonal	NULL
antibodies	NULL
against	NULL
rat	NULL
CREBa	NULL
«	NULL
(	NULL
25	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

These	NULL
results	NULL
show	NULL
that	NULL
the	NULL
CREB-1	NULL
protein	NULL
is	NULL
a	NULL
component	NULL
of	NULL
all	NULL
four	NULL
EMSA	NULL
complexes	NULL
formed	NULL
on	NULL
LDHA-CRE	NULL
.	NULL

Induction	NULL
of	NULL
CREB	NULL
Complexes	NULL
in	NULL
T	NULL
Lymphocytes	NULL
-	NULL
Mitogen	NULL
+Mitogen	NULL
CRE	NULL
molar	NULL
excese	NULL
0	NULL
510	NULL
25	NULL
50	NULL
100	NULL
0	NULL
5	NULL
10	NULL
25	NULL
50	NULL
100	NULL
nd	NULL
lly	NULL
wine	NULL
<	NULL
n	NULL
>	NULL
>	NULL
>	NULL
Clip	NULL
A1	NULL
A=	NULL
``	NULL
B1	NULL
B2	NULL
Free	NULL
CRE	NULL
AP1	NULL
molar	NULL
excess	NULL
0	NULL
5	NULL
10	NULL
25	NULL
50100	NULL
0	NULL
5	NULL
10	NULL
25	NULL
50	NULL
100	NULL
A1	NULL
-	NULL
%	NULL
e	NULL
_	NULL
$	NULL
$	NULL
-=	NULL
m	NULL
>	NULL
#	NULL
0	NULL
.c	NULL
Free	NULL
CRE	NULL
19721	NULL
-	NULL
Mitogen	NULL
+Mitogen	NULL
CRE	NULL
molar	NULL
excess	NULL
-	NULL
O0	NULL
19	NULL
25	NULL
50	NULL
100	NULL
0	NULL
_	NULL
0	NULL
10	NULL
25	NULL
50	NULL
100	NULL
Al	NULL
A2	NULL
-	NULL
‘	NULL
Free	NULL
AP1	NULL
AP1	NULL
molar	NULL
excess	NULL
0	NULL
10	NULL
25	NULL
50	NULL
100	NULL
0	NULL
0	NULL
10	NULL
25	NULL
50	NULL
100	NULL
A1	NULL
AZ	NULL
--	NULL
ﬁw	NULL
‘	NULL
Free	NULL
AP1	NULL
-|	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

The	NULL
T	NULL
lymphocyte	NULL
nuclear	NULL
binding	NULL
activity	NULL
is	NULL
specific	NULL
for	NULL
CRE	NULL
.	NULL

Nuclear	NULL
lysates	NULL
were	NULL
prepared	NULL
from	NULL
peripheral	NULL
T	NULL
lymphocytes	NULL
incubated	NULL
48	NULL
h	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
mitogen	NULL
.	NULL

EMSA	NULL
was	NULL
performed	NULL
with	NULL
LDHA-CRE	NULL
(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
or	NULL
AP1	NULL
oligonucleotide	NULL
(	NULL
C	NULL
and	NULL
D	NULL
)	NULL
as	NULL
the	NULL
labeled	NULL
probe	NULL
.	NULL

Competitor	NULL
oligonucleotides	NULL
(	NULL
A	NULL
and	NULL
C	NULL
:	NULL
LDHA-CRE	NULL
,	NULL
5-GCTCCCACTCTGACGTCAGCGCGGAGCTT-3	NULL
'	NULL
;	NULL
B	NULL
and	NULL
D	NULL
:	NULL
AP1	NULL
,	NULL
5'-CCACTCT-GAGTCAGCGCGGAG-3	NULL
'	NULL
)	NULL
,	NULL
were	NULL
added	NULL
in	NULL
molar	NULL
excess	NULL
as	NULL
indicated	NULL
in	NULL
the	NULL
figure	NULL
.	NULL

Lane	NULL
6	NULL
in	NULL
C	NULL
and	NULL
D	NULL
is	NULL
free	NULL
probe	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
nuclear	NULL
extract	NULL
.	NULL

Mitogen	NULL
~	NULL
~	NULL
=	NULL
=	NULL
*	NULL
+	NULL
+o	NULL
+	NULL
Antibody	NULL
(	NULL
ug	NULL
)	NULL
=	NULL
600	NULL
4	NULL
2	NULL
=	NULL
6	NULL
4	NULL
2	NULL
A1	NULL
--	NULL
A2	NULL
--	NULL
B1	NULL
--	NULL
B2	NULL
--	NULL
Free	NULL
probe	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Human	NULL
CREB-1	NULL
monoclonal	NULL
antibody	NULL
inhibits	NULL
protein	NULL
binding	NULL
to	NULL
LDHA-CRE	NULL
.	NULL

Human	NULL
CREB-1	NULL
monoclonal	NULL
antibodies	NULL
(	NULL
0	NULL
,	NULL
2	NULL
,	NULL
4	NULL
,	NULL
or	NULL
6	NULL
ug	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
(	NULL
40	NULL
ug	NULL
)	NULL
from	NULL
mitogen-activated	NULL
and	NULL
non-activated	NULL
peripheral	NULL
T	NULL
lymphocytes	NULL
for	NULL
30	NULL
min	NULL
prior	NULL
to	NULL
adding	NULL
the	NULL
LDHA-CRE	NULL
mobility	NULL
shift	NULL
probe	NULL
.	NULL

EMSA	NULL
was	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

Furthermore	NULL
,	NULL
since	NULL
the	NULL
antibody	NULL
is	NULL
directed	NULL
against	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
,	NULL
the	NULL
experiments	NULL
provide	NULL
strong	NULL
evidence	NULL
that	NULL
CREB	NULL
is	NULL
the	NULL
core	NULL
DNA-binding	NULL
component	NULL
of	NULL
each	NULL
complex	NULL
.	NULL

The	NULL
nuclear	NULL
extracts	NULL
in	NULL
the	NULL
experiments	NULL
in	NULL
Figs	NULL
.	NULL

3	NULL
and	NULL
4	NULL
were	NULL
preincubated	NULL
with	NULL
antibody	NULL
prior	NULL
to	NULL
adding	NULL
the	NULL
oligonucleotide	NULL
probe	NULL
.	NULL

Experiments	NULL
performed	NULL
the	NULL
other	NULL
way	NULL
around	NULL
,	NULL
i.e	NULL
.	NULL

where	NULL
protein-DNA	NULL
complexes	NULL
were	NULL
formed	NULL
prior	NULL
to	NULL
adding	NULL
antibody	NULL
,	NULL
also	NULL
resulted	NULL
in	NULL
complete	NULL
inhibition	NULL
of	NULL
protein	NULL
binding	NULL
to	NULL
LDHA-CRE	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
antibody	NULL
is	NULL
able	NULL
to	NULL
dissociate	NULL
preformed	NULL
CRE-protein	NULL
complexes	NULL
.	NULL

These	NULL
effects	NULL
of	NULL
antibody	NULL
were	NULL
not	NULL
mimicked	NULL
by	NULL
preimmune	NULL
sera	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
idea	NULL
that	NULL
CREB	NULL
in	NULL
each	NULL
complex	NULL
is	NULL
anchored	NULL
to	NULL
CRE	NULL
is	NULL
strengthened	NULL
by	NULL
the	NULL
experiment	NULL
in	NULL
Fig	NULL
.	NULL

4A	NULL
.	NULL

This	NULL
experiment	NULL
shows	NULL
that	NULL
recombinant	NULL
rat	NULL
CREBa	NULL
«	NULL
binds	NULL
to	NULL
LDHA-CRE	NULL
,	NULL
and	NULL
as	NULL
with	NULL
lymphocyte	NULL
nuclear	NULL
extracts	NULL
,	NULL
antibodies	NULL
against	NULL
rat	NULL
CREBa	NULL
prevent	NULL
binding	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
mitogen	NULL
induction	NULL
of	NULL
the	NULL
A1	NULL
and	NULL
A2	NULL
complexes	NULL
can	NULL
be	NULL
accounted	NULL
for	NULL
by	NULL
an	NULL
increase	NULL
in	NULL
CREB	NULL
,	NULL
Western	NULL
blots	NULL
were	NULL
done	NULL
using	NULL
the	NULL
monoclonal	NULL
human	NULL
CREB-1	NULL
antibody	NULL
.	NULL

Fig	NULL
.	NULL

5	NULL
shows	NULL
a	NULL
Western	NULL
analysis	NULL
of	NULL
CREB	NULL
in	NULL
nuclear	NULL
extracts	NULL
of	NULL
non-stimulated	NULL
and	NULL
stimulated	NULL
peripheral	NULL
T-lymphocytes	NULL
.	NULL

Laser	NULL
densitometric	NULL
analysis	NULL
revealed	NULL
a	NULL
slight	NULL
increase	NULL
(	NULL
maxi-mum	NULL
42	NULL
%	NULL
)	NULL
of	NULL
CREB	NULL
upon	NULL
mitogen	NULL
stimulation	NULL
.	NULL

This	NULL
increase	NULL
is	NULL
surprisingly	NULL
small	NULL
when	NULL
compared	NULL
to	NULL
those	NULL
observed	NULL
for	NULL
housekeeping	NULL
proteins	NULL
upon	NULL
induction	NULL
by	NULL
mitogen	NULL
(	NULL
36	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
conclude	NULL
that	NULL
CREB	NULL
is	NULL
present	NULL
in	NULL
relatively	NULL
constant	NULL
amounts	NULL
throughout	NULL
the	NULL
lymphocyte	NULL
cell	NULL
cycle	NULL
and	NULL
probably	NULL
does	NULL
not	NULL
account	NULL
for	NULL
formation	NULL
of	NULL
the	NULL
additional	NULL
A1	NULL
and	NULL
A2	NULL
complexes	NULL
.	NULL

Phosphorylation	NULL
of	NULL
CREB	NULL
promotes	NULL
both	NULL
homodimerization	NULL
(	NULL
37	NULL
)	NULL
and	NULL
heterodimerization	NULL
(	NULL
38-42	NULL
)	NULL
.	NULL

To	NULL
test	NULL
if	NULL
phosphorylation	NULL
19722	NULL
A	NULL
Lymphocytes	NULL
Induction	NULL
of	NULL
CREB	NULL
Complexes	NULL
in	NULL
T	NULL
Lymphocytes	NULL
BL	NULL
21	NULL
R	NULL
i	NULL
B	NULL
-	NULL
Mitogen	NULL
+	NULL
Mitogen	NULL
Nuclear	NULL
Extract	NULL
+	NULL
+o	NULL
g	NULL
o=	NULL
>	NULL
>	NULL
.	NULL

2	NULL
2	NULL
_	NULL
_	NULL
``	NULL
``	NULL
D	NULL
Antisera	NULL
-	NULL
=	NULL
*+	NULL
=	NULL
*	NULL
~	NULL
.	NULL

toi	NULL
(	NULL
Mitogen	NULL
=	NULL
+	NULL
#	NULL
0	NULL
&	NULL
&	NULL
=	NULL
Preimmune	NULL
sera	NULL
=	NULL
=	NULL
*	NULL
*	NULL
0	NULL
ao	NULL
*	NULL
#	NULL
CREBa	NULL
=	NULL
~	NULL
om	NULL
t	NULL
+	NULL
+	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

Rat	NULL
CREBa	NULL
«	NULL
antibodies	NULL
inhibit	NULL
binding	NULL
of	NULL
T	NULL
lymphocyte	NULL
nuclear	NULL
factors	NULL
and	NULL
recombinant	NULL
rat	NULL
CREBa	NULL
protein	NULL
to	NULL
LDHA-CRE	NULL
.	NULL

A	NULL
,	NULL
EM-SAs	NULL
were	NULL
performed	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
non-activated	NULL
and	NULL
mitogen-activated	NULL
peripheral	NULL
T	NULL
lymphocytes	NULL
(	NULL
left	NULL
side	NULL
)	NULL
or	NULL
with	NULL
lysates	NULL
of	NULL
Escherichia	NULL
coli	NULL
BL21	NULL
in	NULL
which	NULL
recombinant	NULL
rat	NULL
CREBa	NULL
had	NULL
been	NULL
expressed	NULL
or	NULL
not	NULL
.	NULL

Nuclear	NULL
extracts	NULL
and	NULL
antibodies	NULL
against	NULL
rat	NULL
CREBa	NULL
protein	NULL
were	NULL
preincubated	NULL
on	NULL
ice	NULL
for	NULL
30	NULL
min	NULL
prior	NULL
to	NULL
addition	NULL
of	NULL
the	NULL
LDHA-CRE	NULL
probe	NULL
.	NULL

B	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
non-activated	NULL
and	NULL
mitogen-activated	NULL
peripheral	NULL
T	NULL
lymphocytes	NULL
were	NULL
preincubated	NULL
with	NULL
preimmune	NULL
sera	NULL
or	NULL
antibodies	NULL
against	NULL
rat	NULL
CREB	NULL
.	NULL

A1	NULL
CREBa	NULL
Antibody	NULL
_-	NULL
+	NULL
wt	NULL
tiie	NULL
<	NULL
#	NULL
:	NULL
%	NULL
Mitogen	NULL
m	NULL
+	NULL
-	NULL
67	NULL
K	NULL
-	NULL
43	NULL
<	NULL
-	NULL
30	NULL
K	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
of	NULL
CREB	NULL
in	NULL
non-activated	NULL
and	NULL
mitogen-activated	NULL
peripheral	NULL
T-lymphocytes	NULL
.	NULL

Nuclear	NULL
extracts	NULL
(	NULL
100	NULL
ug	NULL
)	NULL
were	NULL
applied	NULL
to	NULL
each	NULL
lane	NULL
on	NULL
a	NULL
1.5-mm	NULL
10	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

After	NULL
electrophoresis	NULL
and	NULL
blotting	NULL
to	NULL
a	NULL
nitrocellulose	NULL
filter	NULL
,	NULL
the	NULL
filters	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
monoclonal	NULL
antibody	NULL
against	NULL
human	NULL
CREB-1	NULL
.	NULL

CREB	NULL
was	NULL
detected	NULL
by	NULL
secondary	NULL
antibodies	NULL
conjugated	NULL
with	NULL
alkaline	NULL
phosphatase	NULL
.	NULL

Molecular	NULL
weight	NULL
markers	NULL
are	NULL
shown	NULL
to	NULL
the	NULL
right	NULL
.	NULL

plays	NULL
a	NULL
role	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
A1	NULL
and	NULL
A2	NULL
complexes	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
dephosphorylated	NULL
with	NULL
acid	NULL
phosphatase	NULL
.	NULL

Fig	NULL
.	NULL

6	NULL
shows	NULL
that	NULL
phosphatase	NULL
treatment	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
both	NULL
non-activated	NULL
and	NULL
mitogen-activated	NULL
cells	NULL
strongly	NULL
inhibits	NULL
all	NULL
CREB	NULL
binding	NULL
to	NULL
LDHA-CRE	NULL
.	NULL

However	NULL
,	NULL
formation	NULL
of	NULL
all	NULL
four	NULL
complexes	NULL
was	NULL
restored	NULL
upon	NULL
rephosphorylation	NULL
of	NULL
these	NULL
nuclear	NULL
extracts	NULL
with	NULL
the	NULL
catalytic	NULL
subunit	NULL
of	NULL
cAMP-dependent	NULL
protein	NULL
kinase	NULL
.	NULL

Incubation	NULL
of	NULL
dephosphorylated	NULL
nuclear	NULL
extracts	NULL
with	NULL
ATP	NULL
alone	NULL
also	NULL
resulted	NULL
in	NULL
a	NULL
weak	NULL
restoration	NULL
of	NULL
binding	NULL
activity	NULL
,	NULL
presumably	NULL
due	NULL
to	NULL
endogenous	NULL
kinase	NULL
activity	NULL
.	NULL

This	NULL
result	NULL
shows	NULL
that	NULL
formation	NULL
of	NULL
all	NULL
four	NULL
EMSA	NULL
complexes	NULL
on	NULL
LDHA-CRE	NULL
requires	NULL
phosphorylation	NULL
,	NULL
presumably	NULL
of	NULL
CREB	NULL
.	NULL

It	NULL
is	NULL
important	NULL
to	NULL
note	NULL
,	NULL
however	NULL
,	NULL
that	NULL
complexes	NULL
A1	NULL
and	NULL
A2	NULL
are	NULL
not	NULL
induced	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
non-stimulated	NULL
cells	NULL
by	NULL
phosphorylation	NULL
with	NULL
either	NULL
exogenous	NULL
PKA	NULL
or	NULL
endogenous	NULL
kinases	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Induction	NULL
of	NULL
complexes	NULL
A1	NULL
and	NULL
A2	NULL
therefore	NULL
must	NULL
be	NULL
due	NULL
to	NULL
expression	NULL
of	NULL
new	NULL
nuclear	NULL
factors	NULL
that	NULL
het-erodimerize	NULL
with	NULL
CREB	NULL
,	NULL
rather	NULL
than	NULL
to	NULL
a	NULL
phosphorylation-dependent	NULL
heterodimerization	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
the	NULL
nuclear	NULL
CRE-binding	NULL
factor	NULL
induced	NULL
in	NULL
peripheral	NULL
lymphocytes	NULL
is	NULL
also	NULL
present	NULL
in	NULL
transformed	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
prepared	NULL
nuclear	NULL
extracts	NULL
from	NULL
Jurkat	NULL
cells	NULL
.	NULL

These	NULL
extracts	NULL
form	NULL
mobility	NULL
shift	NULL
complexes	NULL
with	NULL
LDHA-CRE	NULL
,	NULL
which	NULL
have	NULL
-	NULL
Mitogen	NULL
+	NULL
Mitogen	NULL
[	NULL
-	NULL
11	NULL
1	NULL
Phosphatase	NULL
=	NULL
+	NULL
+o	NULL
+	NULL
=	NULL
%	NULL
:	NULL
ATP	NULL
=	NULL
=	NULL
+o	NULL
+	NULL
=	NULL
=	NULL
+	NULL
PKA	NULL
=	NULL
-	NULL
£	NULL
%	NULL
=	NULL
=	NULL
£	NULL
i=	NULL
A-A2	NULL
--	NULL
B1	NULL
--	NULL
Ba-	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

Phosphorylation	NULL
of	NULL
lymphocyte	NULL
nuclear	NULL
factors	NULL
is	NULL
required	NULL
for	NULL
protein	NULL
binding	NULL
to	NULL
LDHA-CRE	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
mitogen-stimulated	NULL
and	NULL
non-stimulated	NULL
peripheral	NULL
T	NULL
lymphocytes	NULL
were	NULL
incubated	NULL
for	NULL
60	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
2	NULL
units	NULL
of	NULL
acid	NULL
phosphatase	NULL
linked	NULL
to	NULL
Sepharose	NULL
.	NULL

After	NULL
removal	NULL
of	NULL
the	NULL
phosphat-ase-Sepharose	NULL
,	NULL
an	NULL
aliquote	NULL
of	NULL
the	NULL
supernatant	NULL
was	NULL
rephosphorylated	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
3	NULL
units	NULL
)	NULL
or	NULL
absence	NULL
of	NULL
the	NULL
catalytic	NULL
subunit	NULL
of	NULL
the	NULL
porcine	NULL
cAMP-dependent	NULL
protein	NULL
kinase	NULL
(	NULL
PKA	NULL
)	NULL
.	NULL

Protein	NULL
was	NULL
measured	NULL
,	NULL
and	NULL
equal	NULL
amounts	NULL
of	NULL
both	NULL
the	NULL
dephosphorylated	NULL
and	NULL
the	NULL
phosphorylated	NULL
samples	NULL
were	NULL
taken	NULL
for	NULL
EMSA	NULL
.	NULL

The	NULL
gel	NULL
retardation	NULL
assay	NULL
was	NULL
performed	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
using	NULL
LDHA-CRE	NULL
as	NULL
the	NULL
labeled	NULL
probe	NULL
.	NULL

mobilities	NULL
similar	NULL
to	NULL
the	NULL
A1	NULL
,	NULL
B1	NULL
,	NULL
and	NULL
B2	NULL
complexes	NULL
in	NULL
mitogen-activated	NULL
peripheral	NULL
T	NULL
lymphocytes	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

Competitor	NULL
LDHA-CRE	NULL
oligonucleotide	NULL
inhibited	NULL
formation	NULL
of	NULL
the	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
AP1	NULL
oligonucleotide	NULL
(	NULL
500	NULL
molar	NULL
excess	NULL
)	NULL
and	NULL
several	NULL
other	NULL
specific	NULL
synthetic	NULL
oligonucleotides	NULL
(	NULL
see	NULL
above	NULL
)	NULL
did	NULL
not	NULL
.	NULL

Phosphatase	NULL
treatment	NULL
of	NULL
Jurkat	NULL
nuclear	NULL
extracts	NULL
also	NULL
inhibits	NULL
binding	NULL
to	NULL
LDHA-CRE	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

Formation	NULL
of	NULL
complex	NULL
I	NULL
(	NULL
corresponding	NULL
in	NULL
mobility	NULL
to	NULL
complex	NULL
A	NULL
)	NULL
was	NULL
strongly	NULL
inhib-ited	NULL
,	NULL
whereas	NULL
formation	NULL
of	NULL
complex	NULL
II	NULL
(	NULL
corresponding	NULL
to	NULL
com	NULL
Induction	NULL
of	NULL
CREB	NULL
Complexes	NULL
in	NULL
T	NULL
Lymphocytes	NULL
CRE	NULL
AP1	NULL
Molar	NULL
excess	NULL
0	NULL
_	NULL
25	NULL
50	NULL
125	NULL
250	NULL
500	NULL
25	NULL
50125	NULL
250	NULL
500	NULL
x	NULL
-	NULL
lik	NULL
«	NULL
see	NULL
»	NULL
82	NULL
=	NULL
ae	NULL
v	NULL
i	NULL
``	NULL
``	NULL
‘	NULL
.	NULL

Free	NULL
CRE	NULL
Fic	NULL
.	NULL

7	NULL
.	NULL

Gel	NULL
retardation	NULL
analysis	NULL
of	NULL
Jurkat	NULL
cell	NULL
nuclear	NULL
factors	NULL
which	NULL
bind	NULL
LDHA-CRE	NULL
.	NULL

EMSA	NULL
was	NULL
conducted	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
with	NULL
Jurkat	NULL
nuclear	NULL
extracts	NULL
and	NULL
radiolabeled	NULL
LDHA-CRE	NULL
probe	NULL
.	NULL

Unlabeled	NULL
LDHA-CRE	NULL
oligonucleotide	NULL
(	NULL
CRE	NULL
)	NULL
or	NULL
AP1	NULL
oligonucleotide	NULL
(	NULL
AP1	NULL
)	NULL
were	NULL
added	NULL
as	NULL
competitor	NULL
DNAs	NULL
during	NULL
the	NULL
binding	NULL
reaction	NULL
.	NULL

Jurkat	NULL
HepG2	NULL
[	NULL
1T	NULL
|	NULL
Phosphatase	NULL
=	NULL
+	NULL
+o	NULL
+	NULL
=	NULL
+	NULL
+	NULL
+	NULL
ATP	NULL
=	NULL
=	NULL
_	NULL
%	NULL
+	NULL
=	NULL
inf	NULL
amend	NULL
PKA	NULL
=	NULL
=o	NULL
4	NULL
o=	NULL
=	NULL
=~	NULL
~	NULL
+	NULL
=	NULL
Free	NULL
probe	NULL
Fic	NULL
.	NULL

8	NULL
.	NULL

Phosphorylation	NULL
of	NULL
Jurkat	NULL
and	NULL
HepG2	NULL
cell	NULL
nuclear	NULL
extracts	NULL
is	NULL
required	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
LDHA-CRE	NULL
.	NULL

Jurkat	NULL
and	NULL
HepG2	NULL
nuclear	NULL
extracts	NULL
were	NULL
dephosphorylated	NULL
with	NULL
acid	NULL
phosphatase	NULL
and	NULL
rephosphorylated	NULL
with	NULL
PKA	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

The	NULL
mobility	NULL
of	NULL
band	NULL
I	NULL
is	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
lymphocyte	NULL
complexes	NULL
A1	NULL
and	NULL
A2	NULL
,	NULL
and	NULL
the	NULL
mobilities	NULL
of	NULL
bands	NULL
II	NULL
and	NULL
III	NULL
are	NULL
similar	NULL
to	NULL
complexes	NULL
B1	NULL
and	NULL
B2	NULL
.	NULL

The	NULL
gel	NULL
retardation	NULL
assay	NULL
was	NULL
done	NULL
with	NULL
labeled	NULL
LDHA-CRE	NULL
as	NULL
the	NULL
probe	NULL
.	NULL

plex	NULL
B	NULL
)	NULL
was	NULL
partially	NULL
inhibited	NULL
.	NULL

Rephosphorylation	NULL
of	NULL
the	NULL
extracts	NULL
with	NULL
exogenous	NULL
PKA	NULL
or	NULL
endogenous	NULL
kinases	NULL
fully	NULL
or	NULL
partially	NULL
restored	NULL
the	NULL
individual	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
HepG2	NULL
hepatoma	NULL
cells	NULL
also	NULL
contained	NULL
CRE	NULL
binding	NULL
activity	NULL
,	NULL
which	NULL
was	NULL
dependent	NULL
upon	NULL
phosphorylation	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
low	NULL
mobility	NULL
complex	NULL
I	NULL
was	NULL
barely	NULL
detectable	NULL
in	NULL
HepG2	NULL
cells	NULL
,	NULL
raising	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
inducible	NULL
CREB	NULL
dimerization	NULL
partner	NULL
is	NULL
a	NULL
lymphoid	NULL
cell-specific	NULL
nuclear	NULL
factor	NULL
.	NULL

DISCUSSION	NULL
In	NULL
the	NULL
present	NULL
study	NULL
we	NULL
demonstrate	NULL
the	NULL
induction	NULL
of	NULL
nuclear	NULL
CRE	NULL
binding	NULL
activity	NULL
in	NULL
mitogen-activated	NULL
peripheral	NULL
T	NULL
lymphocytes	NULL
.	NULL

Four	NULL
CRE-binding	NULL
complexes	NULL
are	NULL
detected	NULL
in	NULL
T	NULL
cell	NULL
19723	NULL
nuclear	NULL
extracts	NULL
by	NULL
the	NULL
mobility	NULL
retardation	NULL
assay	NULL
.	NULL

Two	NULL
of	NULL
these	NULL
complexes	NULL
(	NULL
with	NULL
highest	NULL
mobilities	NULL
)	NULL
are	NULL
present	NULL
in	NULL
non-activated	NULL
cells	NULL
,	NULL
whereas	NULL
all	NULL
four	NULL
are	NULL
usually	NULL
present	NULL
in	NULL
mitogen-activated	NULL
cells	NULL
.	NULL

CRE	NULL
binding	NULL
activity	NULL
similar	NULL
to	NULL
that	NULL
in	NULL
activated	NULL
T	NULL
lymphocytes	NULL
is	NULL
also	NULL
detected	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
Jurkat	NULL
cells	NULL
,	NULL
suggesting	NULL
a	NULL
possible	NULL
relationship	NULL
to	NULL
growth	NULL
activation	NULL
.	NULL

All	NULL
four	NULL
gel	NULL
shift	NULL
complexes	NULL
bind	NULL
specifically	NULL
to	NULL
a	NULL
synthetic	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
palindromic	NULL
cAMP	NULL
response	NULL
element	NULL
,	NULL
TGACGTCA	NULL
.	NULL

Thus	NULL
,	NULL
each	NULL
complex	NULL
contains	NULL
a	NULL
core	NULL
CRE-binding	NULL
protein	NULL
.	NULL

A	NULL
number	NULL
of	NULL
CRE-binding	NULL
proteins	NULL
have	NULL
been	NULL
identified	NULL
,	NULL
including	NULL
CREB	NULL
(	NULL
43	NULL
,	NULL
44	NULL
)	NULL
,	NULL
CREB-2	NULL
(	NULL
45	NULL
)	NULL
,	NULL
CREM	NULL
(	NULL
46	NULL
)	NULL
,	NULL
members	NULL
of	NULL
the	NULL
ATF	NULL
family	NULL
(	NULL
33	NULL
)	NULL
,	NULL
CRE-BP	NULL
(	NULL
47	NULL
)	NULL
,	NULL
and	NULL
mXBP	NULL
(	NULL
48	NULL
)	NULL
.	NULL

We	NULL
do	NULL
not	NULL
presently	NULL
know	NULL
which	NULL
of	NULL
these	NULL
are	NULL
present	NULL
in	NULL
peripheral	NULL
T	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
our	NULL
studies	NULL
based	NULL
on	NULL
antibody	NULL
experiments	NULL
suggest	NULL
that	NULL
the	NULL
43-kDa	NULL
CREB-1	NULL
protein	NULL
is	NULL
present	NULL
in	NULL
all	NULL
four	NULL
complexes	NULL
.	NULL

If	NULL
so	NULL
,	NULL
the	NULL
four	NULL
CREB-1-containing	NULL
complexes	NULL
can	NULL
only	NULL
be	NULL
formed	NULL
through	NULL
heterodimerization	NULL
(	NULL
35	NULL
,	NULL
42	NULL
,	NULL
48	NULL
)	NULL
,	NULL
and	NULL
CREB-1	NULL
must	NULL
be	NULL
the	NULL
common	NULL
component	NULL
in	NULL
each	NULL
complex	NULL
.	NULL

This	NULL
finding	NULL
,	NULL
together	NULL
with	NULL
the	NULL
effects	NULL
of	NULL
phosphorylation	NULL
(	NULL
see	NULL
be-low	NULL
)	NULL
,	NULL
implies	NULL
that	NULL
CREB-1	NULL
anchors	NULL
the	NULL
multimer	NULL
complexes	NULL
to	NULL
CRE	NULL
.	NULL

However	NULL
,	NULL
the	NULL
possibility	NULL
must	NULL
also	NULL
be	NULL
considered	NULL
that	NULL
some	NULL
of	NULL
these	NULL
complexes	NULL
are	NULL
homodimers	NULL
of	NULL
new	NULL
members	NULL
of	NULL
the	NULL
CREB/ATF	NULL
family	NULL
which	NULL
cross-react	NULL
with	NULL
the	NULL
monoclonal	NULL
antibody	NULL
.	NULL

CREB	NULL
dimerization	NULL
(	NULL
37	NULL
)	NULL
and	NULL
binding	NULL
to	NULL
CRE	NULL
(	NULL
49	NULL
)	NULL
are	NULL
enhanced	NULL
by	NULL
CREB	NULL
phosphorylation	NULL
.	NULL

The	NULL
present	NULL
studies	NULL
support	NULL
this	NULL
view	NULL
.	NULL

Dephosphorylation	NULL
of	NULL
lymphocyte	NULL
,	NULL
Jurkat	NULL
,	NULL
and	NULL
HepG2	NULL
cell	NULL
nuclear	NULL
extracts	NULL
abolished	NULL
formation	NULL
of	NULL
gel	NULL
retardation	NULL
complexes	NULL
with	NULL
LDHA-CRE	NULL
,	NULL
and	NULL
rephosphorylation	NULL
of	NULL
the	NULL
extracts	NULL
with	NULL
PKA	NULL
or	NULL
with	NULL
endogenous	NULL
nuclear	NULL
protein	NULL
kinases	NULL
restored	NULL
binding	NULL
.	NULL

These	NULL
results	NULL
,	NULL
together	NULL
with	NULL
our	NULL
antibody	NULL
studies	NULL
,	NULL
indicate	NULL
that	NULL
all	NULL
four	NULL
nuclear	NULL
complexes	NULL
in	NULL
mitogen-activated	NULL
lymphocytes	NULL
are	NULL
either	NULL
homodimers	NULL
or	NULL
heterodimers	NULL
of	NULL
CREB	NULL
that	NULL
are	NULL
phosphorylated	NULL
in	NULL
vivo	NULL
.	NULL

Strong	NULL
rephosphorylation	NULL
of	NULL
the	NULL
complexes	NULL
by	NULL
PKA	NULL
suggests	NULL
that	NULL
the	NULL
PKA	NULL
site	NULL
on	NULL
CREB	NULL
is	NULL
responsible	NULL
for	NULL
re-establishing	NULL
CRE	NULL
binding	NULL
properties	NULL
.	NULL

Although	NULL
induction	NULL
of	NULL
additional	NULL
gel	NULL
retardation	NULL
complexes	NULL
by	NULL
mitogen	NULL
activation	NULL
might	NULL
be	NULL
explained	NULL
by	NULL
the	NULL
phosphorylation	NULL
of	NULL
existing	NULL
transfactors	NULL
(	NULL
50	NULL
)	NULL
,	NULL
our	NULL
results	NULL
show	NULL
that	NULL
phosphorylation	NULL
does	NULL
not	NULL
account	NULL
for	NULL
formation	NULL
of	NULL
the	NULL
A1	NULL
and	NULL
A2	NULL
complexes	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
non-activated	NULL
cells	NULL
do	NULL
not	NULL
form	NULL
these	NULL
complexes	NULL
after	NULL
phosphorylation	NULL
with	NULL
PKA	NULL
or	NULL
endogenous	NULL
kinases	NULL
.	NULL

Furthermore	NULL
,	NULL
Western	NULL
blot	NULL
analysis	NULL
shows	NULL
that	NULL
the	NULL
CREB	NULL
is	NULL
present	NULL
at	NULL
relatively	NULL
constant	NULL
levels	NULL
during	NULL
T	NULL
cell	NULL
growth	NULL
and	NULL
activation	NULL
.	NULL

Thus	NULL
,	NULL
our	NULL
data	NULL
strongly	NULL
imply	NULL
that	NULL
mi-togens	NULL
increase	NULL
a	NULL
new	NULL
nuclear	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
that	NULL
dimerizes	NULL
with	NULL
CREB	NULL
.	NULL

This	NULL
factor	NULL
could	NULL
be	NULL
transported	NULL
from	NULL
the	NULL
cytosol	NULL
upon	NULL
phosphorylation	NULL
,	NULL
or	NULL
its	NULL
synthesis	NULL
could	NULL
be	NULL
induced	NULL
.	NULL

With	NULL
regard	NULL
to	NULL
the	NULL
latter	NULL
,	NULL
a	NULL
number	NULL
of	NULL
potential	NULL
dimer	NULL
combinations	NULL
,	NULL
such	NULL
as	NULL
CREB/CREM	NULL
(	NULL
46	NULL
)	NULL
and	NULL
ATF-1/Jun-Fos	NULL
(	NULL
35	NULL
)	NULL
,	NULL
have	NULL
been	NULL
demon-strated	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
several	NULL
T	NULL
cell-specific	NULL
CRE-binding	NULL
proteins	NULL
have	NULL
been	NULL
identified	NULL
that	NULL
retain	NULL
dimerization	NULL
domains	NULL
similar	NULL
to	NULL
those	NULL
in	NULL
CREB	NULL
,	NULL
c-Jun	NULL
,	NULL
c-Fos	NULL
,	NULL
and	NULL
CRE-BP	NULL
(	NULL
35	NULL
,	NULL
46	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
a	NULL
broad	NULL
spectrum	NULL
of	NULL
potential	NULL
CRE	NULL
binding	NULL
complexes	NULL
are	NULL
available	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
identity	NULL
of	NULL
the	NULL
inducible	NULL
factor	NULL
remains	NULL
to	NULL
be	NULL
studied	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
new	NULL
CREB	NULL
complexes	NULL
in	NULL
activated	NULL
peripheral	NULL
T	NULL
cells	NULL
and	NULL
Jurkat	NULL
cells	NULL
further	NULL
implicates	NULL
cAMP	NULL
in	NULL
T	NULL
cell	NULL
growth	NULL
processes	NULL
,	NULL
although	NULL
its	NULL
exact	NULL
role	NULL
is	NULL
complicated	NULL
and	NULL
far	NULL
from	NULL
understood	NULL
.	NULL

On	NULL
one	NULL
hand	NULL
,	NULL
experimental	NULL
manipulations	NULL
that	NULL
raise	NULL
cellular	NULL
cAMP	NULL
levels	NULL
inhibit	NULL
interleukin-2	NULL
production	NULL
and	NULL
DNA	NULL
synthesis	NULL
,	NULL
while	NULL
,	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
several	NULL
reports	NULL
have	NULL
demonstrated	NULL
that	NULL
mitogen	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
is	NULL
associated	NULL
with	NULL
increased	NULL
cellular	NULL
levels	NULL
of	NULL
cAMP	NULL
(	NULL
see	NULL
Introduction	NULL
19724	NULL
for	NULL
review	NULL
)	NULL
.	NULL

A	NULL
positive	NULL
role	NULL
for	NULL
cAMP	NULL
in	NULL
cell	NULL
growth	NULL
would	NULL
not	NULL
be	NULL
surprising	NULL
in	NULL
view	NULL
of	NULL
the	NULL
large	NULL
number	NULL
of	NULL
housekeeping	NULL
genes	NULL
that	NULL
are	NULL
regulated	NULL
through	NULL
cAMP	NULL
response	NULL
elements	NULL
(	NULL
51	NULL
)	NULL
.	NULL

However	NULL
,	NULL
whether	NULL
the	NULL
mitogen-induced	NULL
CREB	NULL
complexes	NULL
function	NULL
in	NULL
lymphocytes	NULL
as	NULL
gene	NULL
activators	NULL
,	NULL
suppressors	NULL
,	NULL
or	NULL
both	NULL
remains	NULL
an	NULL
open	NULL
question	NULL
.	NULL

Both	NULL
functions	NULL
have	NULL
been	NULL
assigned	NULL
to	NULL
CREB	NULL
(	NULL
39	NULL
)	NULL
and	NULL
other	NULL
CRE-related	NULL
proteins	NULL
(	NULL
45	NULL
,	NULL
46	NULL
)	NULL
.	NULL

Identification	NULL
and	NULL
further	NULL
characterization	NULL
of	NULL
the	NULL
inducible	NULL
CREB	NULL
dimerization	NULL
partners	NULL
reported	NULL
here	NULL
should	NULL
provide	NULL
some	NULL
insight	NULL
into	NULL
the	NULL
role	NULL
of	NULL
cAMP	NULL
in	NULL
T	NULL
cell	NULL
growth	NULL
and	NULL
activation	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
present	NULL
demonstration	NULL
that	NULL
both	NULL
human	NULL
and	NULL
rat	NULL
CREB	NULL
binds	NULL
specifically	NULL
to	NULL
the	NULL
LDHA-CRE	NULL
oligonucleotide	NULL
supports	NULL
and	NULL
extends	NULL
earlier	NULL
findings	NULL
that	NULL
the	NULL
LDH-A	NULL
gene	NULL
contains	NULL
a	NULL
functional	NULL
cAMP	NULL
response	NULL
element	NULL
(	NULL
31	NULL
,	NULL
32	NULL
)	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
I.	NULL
Pongratz	NULL
for	NULL
supplying	NULL
the	NULL
glucocorticoid	NULL
response	NULL
element	NULL
,	NULL
estrogen	NULL
response	NULL
element	NULL
,	NULL
and	NULL
xenobiotic	NULL
response	NULL
element	NULL
oligonucleotide	NULL
probes	NULL
and	NULL
Dr.	NULL
J.	NULL
Lund	NULL
for	NULL
the	NULL
rat	NULL
CREBa	NULL
antisera	NULL
and	NULL
recombinant	NULL
rat	NULL
CREBa	NULL
protein	NULL
used	NULL
in	NULL
this	NULL
study	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Kaever	NULL
,	NULL
V.	NULL
,	NULL
and	NULL
Resch	NULL
,	NULL
K.	NULL
(	NULL
1985	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
846	NULL
,	NULL
216-225	NULL
2	NULL
.	NULL

Chouaib	NULL
,	NULL
S.	NULL
,	NULL
Welte	NULL
,	NULL
K.	NULL
,	NULL
Mertelsmann	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Dupont	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

135	NULL
,	NULL
1172-1179	NULL
3	NULL
.	NULL

Farrar	NULL
,	NULL
W.	NULL
L.	NULL
,	NULL
Evans	NULL
,	NULL
S.	NULL
W.	NULL
,	NULL
Rapp	NULL
,	NULL
U.	NULL
R.	NULL
,	NULL
and	NULL
Cleveland	NULL
,	NULL
J.	NULL
L.	NULL
(	NULL
1987	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

189	NULL
,	NULL
2075-2080	NULL
4	NULL
,	NULL
Mary	NULL
,	NULL
D.	NULL
,	NULL
Aussel	NULL
,	NULL
C.	NULL
,	NULL
Ferrua	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Fehlmann	NULL
,	NULL
M.	NULL
(	NULL
1987	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

189	NULL
,	NULL
1179-1184	NULL
5	NULL
.	NULL

Takayama	NULL
,	NULL
H.	NULL
,	NULL
Trenn	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Sitkovsky	NULL
,	NULL
M.	NULL
V.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
2330-2336	NULL
6	NULL
.	NULL

Johnson	NULL
,	NULL
K.	NULL
W.	NULL
,	NULL
Davis	NULL
,	NULL
B.	NULL
H.	NULL
,	NULL
and	NULL
Smith	NULL
,	NULL
K.	NULL
A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

85	NULL
,	NULL
6072-6076	NULL
.	NULL

Lingk	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
Chan	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
and	NULL
Gelfand	NULL
,	NULL
E.	NULL
W.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

145	NULL
,	NULL
449-455	NULL
.	NULL

O'Shea	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
Urdahl	NULL
,	NULL
K.	NULL
B.	NULL
,	NULL
Luong	NULL
,	NULL
H.	NULL
T.	NULL
,	NULL
Chused	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
Samelson	NULL
,	NULL
L.	NULL
E.	NULL
,	NULL
and	NULL
Klausner	NULL
,	NULL
R.	NULL
D.	NULL
(	NULL
1987	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

139	NULL
,	NULL
3463-3469	NULL
9	NULL
.	NULL

Klausner	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
O'Shea	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
Luong	NULL
,	NULL
H.	NULL
,	NULL
Ross	NULL
,	NULL
P.	NULL
,	NULL
Bluestone	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Samelson	NULL
,	NULL
L.	NULL
E.	NULL
(	NULL
1987	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

262	NULL
,	NULL
12654-12659	NULL
10	NULL
.	NULL

Aussel	NULL
,	NULL
C.	NULL
,	NULL
Mary	NULL
,	NULL
D.	NULL
,	NULL
Peyron	NULL
,	NULL
J.-F.	NULL
,	NULL
Pelassy	NULL
,	NULL
C.	NULL
,	NULL
Ferrua	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Fehlmann	NULL
,	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

140	NULL
,	NULL
215-220	NULL
11	NULL
.	NULL

Lerner	NULL
,	NULL
A.	NULL
,	NULL
Jacobson	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Miller	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

140	NULL
,	NULL
936-940	NULL
12	NULL
.	NULL

Mary	NULL
,	NULL
D.	NULL
,	NULL
Peyron	NULL
,	NULL
J.-F.	NULL
,	NULL
Auberger	NULL
,	NULL
P.	NULL
,	NULL
Aussel	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Fehlmann	NULL
,	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264	NULL
,	NULL
14498-14502	NULL
13	NULL
.	NULL

Novak	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
and	NULL
Rothenberg	NULL
,	NULL
E.	NULL
V.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
,	NULL
9353-9357	NULL
14	NULL
.	NULL

Wu	NULL
,	NULL
J.	NULL
,	NULL
Dent	NULL
,	NULL
P.	NULL
,	NULL
Wolfman	NULL
,	NULL
A.	NULL
,	NULL
Weber	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
Sturgill	NULL
,	NULL
T.	NULL
W.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
262	NULL
,	NULL
1065-1069	NULL
15	NULL
.	NULL

Cook	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
and	NULL
McCormick	NULL
,	NULL
F.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
262	NULL
,	NULL
1069-1072	NULL
16	NULL
.	NULL

Hadden	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Hadden	NULL
,	NULL
E.	NULL
M.	NULL
,	NULL
Sadlik	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
and	NULL
Coffey	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1976	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

78	NULL
,	NULL
1717-1721	NULL
17	NULL
.	NULL

Wedner	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
Dankner	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Parker	NULL
,	NULL
C.	NULL
W.	NULL
(	NULL
1975	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

115	NULL
,	NULL
1682-1687	NULL
00	NULL
+3	NULL
18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

Induction	NULL
of	NULL
CREB	NULL
Complexes	NULL
in	NULL
T	NULL
Lymphocytes	NULL
Watson	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1976	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

117	NULL
,	NULL
1656-1663	NULL
Takigawa	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Waksman	NULL
,	NULL
B.	NULL
H.	NULL
(	NULL
1981	NULL
)	NULL
Cell	NULL
.	NULL

Immunol	NULL
.	NULL

58	NULL
,	NULL
29-38	NULL
Munoz	NULL
,	NULL
E.	NULL
,	NULL
Beutner	NULL
,	NULL
U.	NULL
,	NULL
Zubiaga	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Huber	NULL
,	NULL
B.	NULL
T.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

144	NULL
,	NULL
964-969	NULL
Wang	NULL
,	NULL
T.	NULL
,	NULL
Sheppard	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
and	NULL
Foker	NULL
,	NULL
J.	NULL
E.	NULL
(	NULL
1978	NULL
)	NULL
Science	NULL
201	NULL
,	NULL
155-157	NULL
Marjanovic	NULL
,	NULL
S.	NULL
,	NULL
Weilburski	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Nelson	NULL
,	NULL
B.	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
970	NULL
,	NULL
372-376	NULL
Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Lebovitz	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
and	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1983	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11	NULL
,	NULL
1475-1489	NULL
Maekawa	NULL
,	NULL
T.	NULL
,	NULL
Sakura	NULL
,	NULL
H.	NULL
,	NULL
Kanei-Ishii	NULL
,	NULL
C.	NULL
,	NULL
Sudo	NULL
,	NULL
T.	NULL
,	NULL
Yoshimura	NULL
,	NULL
T.	NULL
,	NULL
Fujisawa	NULL
,	NULL
J.	NULL
,	NULL
Yoshida	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Ishii	NULL
,	NULL
S.	NULL
(	NULL
1989	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

8	NULL
,	NULL
2023-2028	NULL
Bohm	NULL
,	NULL
S.	NULL
,	NULL
Bakke	NULL
,	NULL
M.	NULL
,	NULL
Nilsson	NULL
,	NULL
M.	NULL
,	NULL
Zanger	NULL
,	NULL
U.	NULL
M.	NULL
,	NULL
Spyro	NULL
,	NULL
U.	NULL
G.	NULL
,	NULL
and	NULL
Lund	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
3952-3963	NULL
Pongratz	NULL
,	NULL
L.	NULL
,	NULL
Stromstedt	NULL
,	NULL
P.-E.	NULL
,	NULL
Mason	NULL
,	NULL
G.	NULL
G.	NULL
F.	NULL
,	NULL
and	NULL
Poellinger	NULL
,	NULL
L.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
16813-16817	NULL
Laemmli	NULL
,	NULL
U.	NULL
K.	NULL
(	NULL
1970	NULL
)	NULL
Nature	NULL
227	NULL
,	NULL
680-685	NULL
Fukasawa	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
and	NULL
Li	NULL
,	NULL
S.	NULL
S.-L.	NULL
(	NULL
1986	NULL
)	NULL
Biochem	NULL
.	NULL

J	NULL
.	NULL

285	NULL
,	NULL
435-439	NULL
Jantzen	NULL
,	NULL
H.-M.	NULL
,	NULL
Strihle	NULL
,	NULL
U.	NULL
,	NULL
Gloss	NULL
,	NULL
B.	NULL
,	NULL
Stewart	NULL
,	NULL
F.	NULL
,	NULL
Schmid	NULL
,	NULL
W.	NULL
,	NULL
Boshart	NULL
,	NULL
M.	NULL
,	NULL
Miksicek	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Schiitz	NULL
,	NULL
G.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
49	NULL
,	NULL
20-38	NULL
Martinez	NULL
,	NULL
E.	NULL
,	NULL
Givel	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Wahli	NULL
,	NULL
W.	NULL
(	NULL
1987	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

6	NULL
,	NULL
3719-3727	NULL
Hou	NULL
,	NULL
E.	NULL
W.	NULL
,	NULL
and	NULL
Li	NULL
,	NULL
S.	NULL
S-L.	NULL
(	NULL
1987	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

1474	NULL
,	NULL
501-505	NULL
Kwast-Welfeld	NULL
,	NULL
J.	NULL
,	NULL
Soong	NULL
,	NULL
C.-J	NULL
.	NULL

,	NULL
Short	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
and	NULL
Jungmann	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264	NULL
,	NULL
6941-6947	NULL
Ziff	NULL
,	NULL
E.	NULL
B	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Trends	NULL
Genet	NULL
.	NULL

6	NULL
,	NULL
69-72	NULL
Brindle	NULL
,	NULL
P.	NULL
K.	NULL
,	NULL
and	NULL
Montminy	NULL
,	NULL
M.	NULL
R.	NULL
(	NULL
1992	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Genet	NULL
.	NULL

Dev	NULL
.	NULL

2	NULL
,	NULL
199-204	NULL
Hai	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Curran	NULL
,	NULL
T.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
3720-3724	NULL
Marjanovic	NULL
,	NULL
S.	NULL
,	NULL
Eriksson	NULL
,	NULL
I.	NULL
,	NULL
and	NULL
Nelson	NULL
,	NULL
B.	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1087	NULL
,	NULL
1-6	NULL
Yamamoto	NULL
,	NULL
K.	NULL
K.	NULL
,	NULL
Gonzalez	NULL
,	NULL
G.	NULL
A.	NULL
,	NULL
Biggs	NULL
,	NULL
W.	NULL
H.	NULL
,	NULL
III	NULL
,	NULL
and	NULL
Montminy	NULL
,	NULL
M.	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
Nature	NULL
884	NULL
,	NULL
494-498	NULL
Yamamoto	NULL
,	NULL
K.	NULL
K.	NULL
,	NULL
Gonzalez	NULL
,	NULL
G.	NULL
A.	NULL
,	NULL
Menzel	NULL
,	NULL
P.	NULL
,	NULL
Rivier	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Montminy	NULL
,	NULL
M.	NULL
R.	NULL
(	NULL
1990	NULL
)	NULL
Cell	NULL
60	NULL
,	NULL
611-617	NULL
Lamph	NULL
,	NULL
W.	NULL
W.	NULL
,	NULL
Dwarki	NULL
,	NULL
V.	NULL
J.	NULL
,	NULL
Ofir	NULL
,	NULL
R.	NULL
,	NULL
Montminy	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Verma	NULL
,	NULL
I.	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

87	NULL
,	NULL
4920-4824	NULL
Quinn	NULL
,	NULL
P.	NULL
Q.	NULL
,	NULL
and	NULL
Granner	NULL
,	NULL
D.	NULL
K.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
3357-3364	NULL
Masson	NULL
,	NULL
N.	NULL
,	NULL
Ellis	NULL
,	NULL
M.	NULL
,	NULL
Goodbourn	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Lee	NULL
,	NULL
K.	NULL
A.	NULL
W.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
1096-1106	NULL
Ransone	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
Wamsley	NULL
,	NULL
P.	NULL
,	NULL
Morley	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
and	NULL
Verma	NULL
,	NULL
I.	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
4565-4573	NULL
Comb	NULL
,	NULL
M.	NULL
,	NULL
Birnberg	NULL
,	NULL
N.	NULL
C.	NULL
,	NULL
Seaholtz	NULL
,	NULL
A.	NULL
,	NULL
Herbert	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Goodman	NULL
,	NULL
H.	NULL
M.	NULL
(	NULL
1986	NULL
)	NULL
Nature	NULL
828	NULL
,	NULL
353-356	NULL
Montminy	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Sevarion	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
Wagner	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Mandel	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Goodman	NULL
,	NULL
R.	NULL
H.	NULL
(	NULL
1986	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
6682-6686	NULL
Karpinski	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Morle	NULL
,	NULL
G.	NULL
D.	NULL
,	NULL
Huggenvik	NULL
,	NULL
J.	NULL
,	NULL
Uhler	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
and	NULL
Leiden	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
4820-4824	NULL
Foulkes	NULL
,	NULL
N.	NULL
S.	NULL
,	NULL
Borrelli	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Sassone-Corsi	NULL
,	NULL
P.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
64	NULL
,	NULL
739-749	NULL
Georgopoulos	NULL
,	NULL
K.	NULL
,	NULL
Morgan	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Moore	NULL
,	NULL
D.	NULL
D.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
747-757	NULL
Ivashkiv	NULL
,	NULL
L.	NULL
B.	NULL
,	NULL
Liou	NULL
,	NULL
H.-C.	NULL
,	NULL
Kara	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Lamph	NULL
,	NULL
W.	NULL
W.	NULL
,	NULL
Verma	NULL
,	NULL
I.	NULL
M.	NULL
,	NULL
and	NULL
Glimcher	NULL
,	NULL
L.	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
1609-1621	NULL
Nichols	NULL
,	NULL
M.	NULL
,	NULL
Weih	NULL
,	NULL
F.	NULL
,	NULL
Schmid	NULL
,	NULL
W.	NULL
,	NULL
DeVack	NULL
,	NULL
C.	NULL
,	NULL
Kowenz-Leutz	NULL
,	NULL
E.	NULL
,	NULL
Luckow	NULL
,	NULL
B.	NULL
,	NULL
Boshart	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Schiitz	NULL
,	NULL
G.	NULL
(	NULL
1992	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

11	NULL
,	NULL
3337-3346	NULL
Chrivia	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Kwok	NULL
,	NULL
R.	NULL
P.	NULL
S.	NULL
,	NULL
Lamb	NULL
,	NULL
N.	NULL
,	NULL
Hagivara	NULL
,	NULL
M.	NULL
,	NULL
Montminy	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
Goodman	NULL
,	NULL
R.	NULL
H.	NULL
(	NULL
1993	NULL
)	NULL
Nature	NULL
365	NULL
,	NULL
855-859	NULL
Mirossay	NULL
,	NULL
L.	NULL
,	NULL
Chastre	NULL
,	NULL
E.	NULL
,	NULL
Empereur	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Gespach	NULL
,	NULL
C.	NULL
(	NULL
1992	NULL
)	NULL
Int	NULL
.	NULL

J.	NULL
Oncol	NULL
.	NULL

1	NULL
,	NULL
8373-385	NULL

